Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1116-1122

  Liu, Zhi Gang ^a   Liu, Li ^a   Xu, Li Hua ^a   Yi, Wei ^a   Tao, Ya Lan ^a   Tu, Zi Wei ^a   Li, Man Zhi ^a   Zeng, Mu Sheng ^a   Xia, Yun Fei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Bmi 1; Mammary carcinoma cells; Radioresistance

Indexed keywords

BMI1 PROTEIN; DOUBLE STRANDED DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL CYCLE; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HISTONES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; REPRESSOR PROTEINS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84863073515     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1615     Document Type: Article

References (43)

1. Jacobs JJ and van Lohuizen M: Cellular memory of transcriptional states by Polycomb-group proteins. Semin Cell Dev Biol 10: 227-235, 1999. (Pubitemid 129502414)
2. Schwartz YB and Pirrotta V: Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 8: 9-22, 2007. (Pubitemid 46006046)
3. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B and Cavalli G: Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745, 2007. (Pubitemid 46273581)
4. Spivakov M and Fisher AG: Epigenetic signatures of stem-cell identity. Nat Rev Genet 8: 263-271, 2007. (Pubitemid 46439288)
5. Rajasekhar VK and Begemann M: Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 25: 2498-2510, 2007. (Pubitemid 47582742)
6. Haupt Y, Alexander WS, Barri G, Klinken SP and Adams JM: Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65: 753-763, 1991. (Pubitemid 121001307)
7. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H and Berns A: Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65: 737-752, 1991. (Pubitemid 121001306)
8. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A and van Lohuizen M: Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 13: 2678-2690, 1999. (Pubitemid 29508555)
9. Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M: The oncogene and Polycomb-group gene Bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-168, 1999. (Pubitemid 29050921)
10. Dimri GP, Martinez JL, Jacobs JJ, et al: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 62: 4736-4745, 2002.
11. Guney I and Sedivy JM: Cellular senescence, epigenetic switches and c-Myc. Cell Cycle 5: 2319-2323, 2006. (Pubitemid 44801376)
12. Datta S, Hoenerhoff MJ, Bommi P, et al: Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways. Cancer Res 67: 10286-10295, 2007. (Pubitemid 350070802)
13. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962-967, 2003. (Pubitemid 37376927)
14. Raaphorst FM: Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol 24: 522-524, 2003.
15. Grinstein E and Wernet P: Cellular signaling in normal and cancerous stem cells. Cell Signal 19: 2428-2433, 2007. (Pubitemid 47531926)
16. Liu S, Dontu G, Mantle ID, et al: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071, 2006.
17. Vrzalikova K, Skarda J, Ehrmann J, et al: Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. J Cancer Res Clin Oncol 134: 1037-1042, 2008.
18. Liu JH, Song LB, Zhang X, et al: Bmi-1 expression predicts prognosis for patients with gastric carcinoma. J Surg Oncol 97: 267-272, 2008. (Pubitemid 351312168)
19. Wang H, Pan K, Zhang HK, et al: Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 134: 535-541, 2008. (Pubitemid 351422607)
20. Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y and Kimura A: Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21: 1116-1122, 2007. (Pubitemid 46672096)
21. Arnes JB, Collett K and Akslen LA: Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. Histopathology 52: 370-380, 2008. (Pubitemid 351208068)
22. Song LB, Zeng MS, Liao WT, et al: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66: 6225-6232, 2006.
23. Qin ZK, Yang JA, Zeng MS, et al: Expression and clinical significance of Bmi-1 protein in bladder cancer. Ai Zheng 27: 1327-1330, 2008 (In Chinese).
24. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005. (Pubitemid 40814659)
25. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008. (Pubitemid 351636299)
26. Yang MH, Hsu DS, Wang HW, et al: Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12: 982-992, 2010.
27. Song LB, Li J, Liao WT, et al: The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636, 2009.
28. Theys J, Jutten B, Habets R, et al: E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiother Oncol 99: 392-397, 2011.
29. Kurrey NK, Jalgaonkar SP, Joglekar AV, et al: Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068, 2009.
30. Guo BH, Feng Y, Zhang R, et al: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 10: 10, 2011.
31. Dimri GP, Itahana K, Acosta M and Campisi J: Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol 20: 273-285, 2000. (Pubitemid 30002569)
32. Liu ZG, Chen HY, Cheng JJ, Chen ZP, Li XN and Xia YF: Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines. Cell Biol Int 33: 1111-1117, 2009.
33. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M and Chen LB: Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260: 406-417, 1995.
34. Lee K, Adhikary G, Balasubramanian S, et al: Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 128: 9-17, 2008. (Pubitemid 350249374)
35. Yan SS, Liu L, Liu ZG, Zeng MS, Song LB and Xia YF: Expression and clinical significance of DNA-PKcs in nasopharyngeal carcinoma. Ai Zheng 27: 979-983, 2008 (In Chinese).
36. Kraus AC, Ferber I, Bachmann SO, et al: In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 21: 8683-8695, 2002. (Pubitemid 36132389)
37. Liang K, Jin W, Knuefermann C, et al: Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. Mol Cancer Ther 2: 353-360, 2003.
38. Soderlund K, Perez-Tenorio G and Stal O: Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells. Int J Oncol 26: 25-32, 2005.
39. LoPiccolo J, Granville CA, Gills JJ and Dennis PA: Targeting Akt in cancer therapy. Anticancer Drugs 18: 861-874, 2007. (Pubitemid 47220704)
40. Lemasters JJ, Qian T, Trost LC, et al: Confocal microscopy of the mitochondrial permeability transition in necrotic and apoptotic cell death. Biochem Soc Symp 66: 205-222, 1999. (Pubitemid 129639033)
41. Kang YH, Yi MJ, Kim MJ, et al: Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 64: 8960-8967, 2004.
42. Kim WH, Park WB, Gao B and Jung MH: Critical role of reactive oxygen species and mitochondrial membrane potential in Korean mistletoe lectin-induced apoptosis in human hepatocarcinoma cells. Mol Pharmacol 66: 1383-1396, 2004. (Pubitemid 39564765)
43. Park MT, Kim MJ, Kang YH, et al: Phytosphingosine in combination with ionizing radiation enhances apoptotic cell death in radiation-resistant cancer cells through ROS-dependent and -independent AIF release. Blood 105: 1724-1733, 2005.